Iron Metabolism, Ferroptosis and COVID-19

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Cell Metabolism".

Deadline for manuscript submissions: closed (15 October 2021) | Viewed by 5234

Special Issue Editor


E-Mail Website
Guest Editor
Department of Life, Health and Environmental Sciences, Università degli Studi dell'Aquila, L'Aquila, Italy
Interests: the biochemical pathways for defense against oxidative stress and the relations between the oxidation state and iron metabolism in chronic diseases and in reproductive aging and infertility; the study of the anti-oxidant, anti-proliferative and anti-inflammatory effects of saffron and its carotenoids

Special Issue Information

Dear Colleagues,

Iron is a transition metal and essential constituent of almost all living cells and organisms. It is a component of various metalloproteins and is involved in critical biochemical processes such as the transport of oxygen in tissues, electron transfer reactions during mitochondrial respiration, the synthesis and repair of DNA, the metabolism of xenobiotics, etc. When present in excess within cells and tissues, iron disrupts redox homeostasis and catalyzes the propagation of reactive oxygen species (ROS), leading to oxidative stress. At the cellular level, oxidative stress may lead to ferroptosis, an iron-dependent form of cell death. Ferroptosis plays an important regulatory role in the occurrence and development of many diseases, such as nervous system diseases including ageusia and anosmia, ischemia/reperfusion injury, tumors etc.

The novel 2019 coronavirus disease (COVID-19) causes acute respiratory distress syndrome (ARDS) in vulnerable individuals. Emerging data link the risk of severe COVID-19 with certain factors such as hyper-inflammation, involving a cytokine storm. Proinflammatory cytokines such as IL6 may induce hyper-ferritinemia in COVID-19 patients. Ferritin is the primary site of iron storage in the cell, and its increase is regulated by the protein hepcidin, a key regulator of iron metabolism in humans.

Recently, a distant sequence similarity between the cysteine-rich cytoplasmic tail of the coronavirus spike protein and the hepcidin protein was reported. This preliminary observation may suggest a potential route of investigation in the coronavirus research field based on the interplay of local and systemic iron regulation, cytokine-mediated inflammatory processes, respiratory infections and the hepcidin protein.

Therefore, this Special Issue of Metabolites will be dedicated to publishing current advances in iron homeostasis, oxidative stress, ferroptosis and COVID-19.

Dr. Anna Maria D'Alessandro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • iron
  • oxidative stress
  • hepcidin
  • ferritin
  • ferroptosis
  • COVID-19
  • endothelial cells
  • hypoxia
  • inflammation
  • ARDS

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 884 KiB  
Article
Dynamics in Anemia Development and Dysregulation of Iron Homeostasis in Hospitalized Patients with COVID-19
by Lukas Lanser, Francesco Robert Burkert, Rosa Bellmann-Weiler, Andrea Schroll, Sophie Wildner, Gernot Fritsche and Günter Weiss
Metabolites 2021, 11(10), 653; https://doi.org/10.3390/metabo11100653 - 25 Sep 2021
Cited by 34 | Viewed by 4090
Abstract
Anemia and disturbances of iron metabolism are frequently encountered in patients with COVID-19 and associated with an adverse clinical course. We retrospectively analyzed 645 consecutive COVID-19 patients hospitalized at the Innsbruck University Hospital. Pre-existing anemia was associated with increased risk for in-hospital death. [...] Read more.
Anemia and disturbances of iron metabolism are frequently encountered in patients with COVID-19 and associated with an adverse clinical course. We retrospectively analyzed 645 consecutive COVID-19 patients hospitalized at the Innsbruck University Hospital. Pre-existing anemia was associated with increased risk for in-hospital death. We further found that the decline in hemoglobin levels during hospital stay is more pronounced in patients with signs of hyperinflammation upon admission, the latter being associated with a nearly two-fold higher risk for new onset anemia within one week. Anemia prevalence increased from 44.3% upon admission to 87.8% in patients who were still hospitalized after two weeks. A more distinct decrease in hemoglobin levels was observed in subjects with severe disease, and new-onset anemia was associated with a higher risk for ICU admission. Transferrin levels decreased within the first week of hospitalization in all patients, however, a continuous decline was observed in subjects who died. Hemoglobin, ferritin, and transferrin levels normalized in a median of 122 days after discharge from hospital. This study uncovers pre-existing anemia as well as low transferrin concentrations as risk factors for mortality in hospitalized COVID-19 patients, whereas new-onset anemia during hospitalization is a risk factor for ICU admission. Anemia and iron disturbances are mainly driven by COVID-19 associated inflammation, and cure from infection results in resolution of anemia and normalization of dysregulated iron homeostasis. Full article
(This article belongs to the Special Issue Iron Metabolism, Ferroptosis and COVID-19)
Show Figures

Figure 1

Back to TopTop